Korea To Revise ‘Innovative Company’ Criteria Amid Calls From Foreign Industry

New Category For Global Companies

South Korea announces planned revisions to a government scheme to designate "innovative" biopharma companies amid allegations of "discrimination" against foreign firms.

innovation
Latest Measures Announced After Economic Ministerial Meeting (Shutterstock)

More from South Korea

More from R&D